2024
Uveitis Onset and Flare-Up: Does the Time of Year Matter?
Surapaneni L, Orlofsky P, Kombo N. Uveitis Onset and Flare-Up: Does the Time of Year Matter? Ocular Immunology And Inflammation 2024, 32: 2299-2305. PMID: 38411923, DOI: 10.1080/09273948.2024.2320701.Peer-Reviewed Original ResearchConceptsComorbid autoimmune conditionsUveitis episodeAutoimmune conditionsPosterior uveitisFlare-upHLA-B27Cases of endogenous uveitisHLA-B27 positive patientsIncidence of flare-upsAnatomic location of uveitisDiagnosis of uveitisLocation of uveitisRetrospective chart reviewNon-infectiousTime of onsetIntermediate uveitisUveitis patientsChronic uveitisAnterior uveitisCommunity-based clinicsEndogenous uveitisUveitis onsetPatient agePositive patientsPanuveitis cases
2019
Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series
Kim J, Materin MA, Sznol M, Kluger H, Weiss S, Chow J, Stoessel K, Kombo N, Del Priore L, Pointdujour-Lim R. Ophthalmic Immune-Related Adverse Events of Immunotherapy: A Single-Site Case Series. Ophthalmology 2019, 126: 1058-1062. PMID: 30735682, PMCID: PMC6933747, DOI: 10.1016/j.ophtha.2019.01.031.Peer-Reviewed Original Research
2016
The Ex-PRESS Glaucoma Filtration Device Implantation in Uveitic Glaucoma
Dhanireddy S, Kombo NC, Payal AR, Freitas-Neto CA, Preble J, Foster CS. The Ex-PRESS Glaucoma Filtration Device Implantation in Uveitic Glaucoma. Ocular Immunology And Inflammation 2016, 25: 767-774. PMID: 27230295, DOI: 10.1080/09273948.2016.1175639.Peer-Reviewed Original ResearchConceptsIntraocular pressureUveitic glaucomaGlaucoma medicationsGlaucoma patientsSurgical successEx-PRESS implantationUveitic glaucoma patientsMean intraocular pressureEffective surgical interventionPostoperative examinationPreoperative levelsGlaucoma groupPreoperative examinationDevice implantationSurgical interventionUG groupControl groupMedicationsPatientsGlaucomaMean numberMonthsSignificant reductionEyesImplantation
2015
A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers
Boonsopon S, Maghsoudlou A, Kombo NE, Foster CS. A Therapeutic Trial of Valganciclovir in Patients with Uveitis and Positive Epstein-Barr virus Early Antigen D IgG Titers. European Journal Of Ophthalmology 2015, 26: 30-35. PMID: 26350994, DOI: 10.5301/ejo.5000673.Peer-Reviewed Original ResearchConceptsPositive Epstein-Barr virusEpstein-Barr virusTherapeutic trialsEBV infection/reactivationInfection/reactivationMassachusetts Eye ResearchCauses of uveitisRetrospective chart reviewImmunoglobulin G titersSurgery institutionsValganciclovir therapyEBV reactivationImmunomodulatory therapyIntraocular inflammationChart reviewIgG titersPersistent inflammationEA antibodyEBV-EAG titersValganciclovirNegative studiesUveitisPatientsInflammation